Jason Adair
Corporate Officer/Principal bij Liquidia Technologies, Inc.
Vermogen: 1 M $ op 30-04-2024
Actieve functies van Jason Adair
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 14-01-2016 | - |
Loopbaan van Jason Adair
Eerdere bekende functies van Jason Adair
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2011 | 01-12-2015 |
| LIQUIDIA CORPORATION | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| Corporate Officer/Principal | - | - |
Opleiding van Jason Adair
| Wake Forest University | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| LIQUIDIA CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
- Beurs
- Insiders
- Jason Adair
- Ervaring
